Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL) Latest Advances

Find the Latest Research About Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)

Last Updated: 06/30/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 463 publications

Treatment outcomes of Hodgkin lymphoma in the Czech Republic.

Treatment outcomes of Hodgkin lymphoma in the Czech Republic.

Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti
Published: May 22, 2026

Utility of ultrasensitive, US Food and Drug Administration-approved κ and λ dual in situ hybridization assay in the diagnosis of Hodgkin lymphomas.

Utility of ultrasensitive, US Food and Drug Administration-approved κ and λ dual in situ hybridization assay in the diagnosis of Hodgkin lymphomas.

Journal: American journal of clinical pathology
Published: March 05, 2026

Nodular lymphocyte-predominant Hodgkin lymphoma controversy and insights: a global NLPHL one working group summit report.

Nodular lymphocyte-predominant Hodgkin lymphoma controversy and insights: a global NLPHL one working group summit report.

Journal: Leukemia
Published: March 02, 2026

Historical outcomes for patients with stage IA NLPHL: RGlobal nLPHL One Working Group (GLOW) retrospective analyses.

Historical outcomes for patients with stage IA NLPHL: RGlobal nLPHL One Working Group (GLOW) retrospective analyses.

Journal: Blood advances
Published: February 05, 2026

​EuroNet-PHL-LP1: Complete resection or low-dose chemo for pediatric low-risk nodular lymphocyte-predominant Hodgkin lymphoma.

​EuroNet-PHL-LP1: Complete resection or low-dose chemo for pediatric low-risk nodular lymphocyte-predominant Hodgkin lymphoma.

Journal: Blood advances
Published: January 16, 2026

Paraneoplastic Hepatitis Associated with Relapsed Nodular Lymphocyte-Predominant Hodgkin Lymphoma.

Paraneoplastic Hepatitis Associated with Relapsed Nodular Lymphocyte-Predominant Hodgkin Lymphoma.

Journal: Hematology reports
Published: January 11, 2026

Nodular Lymphocyte-predominant Hodgkin Lymphoma: Incidence, Pathogenesis, Management.

Nodular Lymphocyte-predominant Hodgkin Lymphoma: Incidence, Pathogenesis, Management.

Journal: Cancer journal (Sudbury, Mass.)
Published: December 20, 2025

Progressive transformation of germinal centers: Bridging clinical and pathological insights for diagnostic precision.

Progressive transformation of germinal centers: Bridging clinical and pathological insights for diagnostic precision.

Journal: Hematology/oncology and stem cell therapy
Published: December 05, 2025

Progressive transformation of germinal centers: Bridging clinical and pathological insights for diagnostic precision.

Progressive transformation of germinal centers: Bridging clinical and pathological insights for diagnostic precision.

Journal: Hematology/oncology and stem cell therapy
Published: December 05, 2025

Promising outcomes of R-CHOP therapy in pediatric nodular lymphocyte-predominant Hodgkin lymphoma: perspectives from a rare subtype.

Promising outcomes of R-CHOP therapy in pediatric nodular lymphocyte-predominant Hodgkin lymphoma: perspectives from a rare subtype.

Journal: Frontiers in oncology
Published: November 05, 2025

T-cell/histiocyte-rich large B-cell lymphoma in the era of novel immunotherapy: A focused review.

T-cell/histiocyte-rich large B-cell lymphoma in the era of novel immunotherapy: A focused review.

Journal: British journal of haematology
Published: September 01, 2025

IgG4 plasma cells in hematopathology: beyond IgG4-related disease.

IgG4 plasma cells in hematopathology: beyond IgG4-related disease.

Journal: Journal of hematopathology
Published: September 01, 2025
Showing 1-12 of 463

Last Updated: 06/30/2026